|Articles|March 19, 2008

NovoLog insulin aspart approved for pediatric use

The Food and Drug Administration approved the NovoLog insulin pump in pediatric patients, aged 4 to 18.


Related to this article

Is it withdrawal or relapse?
In this teaching case, an 18-year-old develops severe anxiety 2 months after stopping long-term fluoxetine because of hyperprolactinemia, raising the question of whether her symptoms reflect antidepressant withdrawal or relapse.